# Venker Eric: insider transactions

SEC CIK 1801917. Roles and transactions as reported on Form 4. Latest Form 4 filed 2026-10-22.

## Roles

| Company | Role | Transactions | First | Latest |
| --- | --- | ---: | --- | --- |
| [Roivant Sciences Ltd.](/companies/roiv.md) | President & Immunovant CEO, Officer | 2 | 2026-10-20 | 2026-10-20 |

## Transactions: 2

Every transaction reported, newest first. Codes P and S are open-market purchases and sales. Reported price is as stated on the form.

| Date | Company | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-20 | [Roivant Sciences Ltd.](/companies/roiv.md) | Sale (S) | 14,144 | $35.42 | $501.0k | [Form 4](/filings/0001635088-26-000116.md) |
| 2026-10-20 | [Roivant Sciences Ltd.](/companies/roiv.md) | Sale (S) | 185,856 | $35.09 | $6.5m | [Form 4](/filings/0001635088-26-000116.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Nov 3, 2026, 01:31 ET. No prices; not investment advice.